Select Committee on European Communities Second Report



Competitiveness

171.  The agricultural and food use of biotechnology is already well established in other major OECD countries such as the United States and Canada and in major food producing countries such as Argentina and China. Any undue delay, cost or burden in Europe will jeopardise the competitive and productive position of our scientific, agricultural, manufacturing and retail industries (John Innes, p 358) and hence employment. It may also improperly restrict future scientific developments. It will also unnecessarily deny consumers access to the products of the technology. GMOs need to be regulated, at least until our knowledge develops further, but it would be extremely damaging if Europe's access to this technology was subjected to inappropriate impediments.


 
previous page contents next page

House of Lords home page Parliament home page House of Commons home page search page enquiries

© Parliamentary copyright 1999